A teofillin és a propranolol hatásának összehasonlító vizsgálata essentialis tremorban.

Translated title of the contribution: Comparative study of theophylline and propranolol in essential tremor

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Propranolol having been used for decades was compared with low dose theophylline and placebo in the treatment of essential tremor. Ten de novo patients with essential tremor were treated for three months in a blind cross-over study. Tremor assessed by volumetric method decreased significantly after one week propranolol (80 mg/day) administration, while it was reduced by theophylline (150 mg/day) after two weeks. There was no difference between the two treatments after four weeks. During the propranolol period tension and dizziness were observed in some cases. According the results both drugs are recommended for treating of essential tremor.

Original languageHungarian
Pages (from-to)981-983
Number of pages3
JournalOrvosi Hetilap
Volume133
Issue number16
Publication statusPublished - Apr 19 1992

Fingerprint

Essential Tremor
Theophylline
Propranolol
Dizziness
Tremor
Cross-Over Studies
Placebos
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A teofillin és a propranolol hatásának összehasonlító vizsgálata essentialis tremorban. / Málly, J.

In: Orvosi Hetilap, Vol. 133, No. 16, 19.04.1992, p. 981-983.

Research output: Contribution to journalArticle

@article{9571b19e41e64e78bc24b7bc1c99fb86,
title = "A teofillin {\'e}s a propranolol hat{\'a}s{\'a}nak {\"o}sszehasonl{\'i}t{\'o} vizsg{\'a}lata essentialis tremorban.",
abstract = "Propranolol having been used for decades was compared with low dose theophylline and placebo in the treatment of essential tremor. Ten de novo patients with essential tremor were treated for three months in a blind cross-over study. Tremor assessed by volumetric method decreased significantly after one week propranolol (80 mg/day) administration, while it was reduced by theophylline (150 mg/day) after two weeks. There was no difference between the two treatments after four weeks. During the propranolol period tension and dizziness were observed in some cases. According the results both drugs are recommended for treating of essential tremor.",
author = "J. M{\'a}lly",
year = "1992",
month = "4",
day = "19",
language = "Hungarian",
volume = "133",
pages = "981--983",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "16",

}

TY - JOUR

T1 - A teofillin és a propranolol hatásának összehasonlító vizsgálata essentialis tremorban.

AU - Málly, J.

PY - 1992/4/19

Y1 - 1992/4/19

N2 - Propranolol having been used for decades was compared with low dose theophylline and placebo in the treatment of essential tremor. Ten de novo patients with essential tremor were treated for three months in a blind cross-over study. Tremor assessed by volumetric method decreased significantly after one week propranolol (80 mg/day) administration, while it was reduced by theophylline (150 mg/day) after two weeks. There was no difference between the two treatments after four weeks. During the propranolol period tension and dizziness were observed in some cases. According the results both drugs are recommended for treating of essential tremor.

AB - Propranolol having been used for decades was compared with low dose theophylline and placebo in the treatment of essential tremor. Ten de novo patients with essential tremor were treated for three months in a blind cross-over study. Tremor assessed by volumetric method decreased significantly after one week propranolol (80 mg/day) administration, while it was reduced by theophylline (150 mg/day) after two weeks. There was no difference between the two treatments after four weeks. During the propranolol period tension and dizziness were observed in some cases. According the results both drugs are recommended for treating of essential tremor.

UR - http://www.scopus.com/inward/record.url?scp=0027123116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027123116&partnerID=8YFLogxK

M3 - Article

VL - 133

SP - 981

EP - 983

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 16

ER -